Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cellular Response
100%
Tumor Treating Fields
100%
Phosphoinositide 3-kinase/Akt Pathway
100%
Cancer Cells
25%
Phosphoinositide 3-kinase (PI3K)
16%
Signaling Pathway
8%
Electric Field (E-field)
8%
Sham
8%
Cell Surface
8%
Phosphorylation
8%
In Cancer
8%
Cell-to-cell
8%
Mouse Model
8%
Immunohistochemistry
8%
Activating mutation
8%
Putative Drug Targets
8%
Cell Response
8%
Glioblastoma
8%
Pharmacological Inhibitors
8%
U87MG
8%
Western Blot Analysis
8%
AKT Pathway
8%
N-cadherin
8%
Ovarian Carcinoma
8%
H1299
8%
Cancer Cell Death
8%
Lung Tumor
8%
Genomic Analysis
8%
Focal Adhesion Kinase
8%
Inhibition Assay
8%
Cell-cell Interaction
8%
Phosphatidylinositol 3-kinase Inhibitor
8%
Field Treatment
8%
Cell Survival Pathways
8%
PIK3CA
8%
Cell Surface Interaction
8%
Multiplex Assay
8%
P110
8%
Non-small Cell Lung Cancer Cells
8%
In Vivo Validation
8%
A2780
8%
Luminex
8%
Concomitant Treatment
8%
Cell Line Models
8%
Glioblastoma Tumor
8%
Phosphatidylinositol 3-kinase/Akt
8%
Tumor Section
8%
Biochemistry, Genetics and Molecular Biology
Signal Transduction
100%
Phosphoinositide 3-Kinase
100%
Protein Kinase B
100%
Cancer Cell
83%
Western Blot
16%
Mouse Model
16%
Cell Death
16%
Cell Survival
16%
H1299
16%
Electric Field
16%
Cell-Cell Interaction
16%
Janus Kinase 1
16%
Phosphoinositide 3-Kinase Inhibitor
16%
Neural Cell Adhesion Molecule
16%
Genomics
16%
phosphorylation
16%
Neuroscience
Cell Signaling
100%
Phosphoinositide 3-Kinase
100%
Protein Kinase B
100%
Tumor Treating Fields
100%
In Vivo
16%
Western Blot
8%
In Vitro
8%
Cell Line
8%
Cell Death
8%
Cell Survival
8%
Immunohistochemistry
8%
Neural Cell Adhesion Molecule
8%
Cell Interaction
8%
Phosphoinositide 3-Kinase Inhibitor
8%
Focal Adhesion Kinase
8%
Janus Kinase 1
8%
Genetics
8%
phosphorylation
8%